AABME is conducting a series of webinars to examine a risk-based, conceptual framework developed by the US Food and Drug Administration (FDA) for use at point-of-care manufacturing facilities. Webinar panels will include speakers from diverse groups, including medical device manufacturers, point-of-care manufacturers, technology developers, and the FDA. The framework includes the following scenarios: A. Minimal Risk 3DP by a Healthcare Professional B&C. Device Designed by Manufacturer Using Validated Process D. Manufacturer Co-Located at Point of Care E. Healthcare Facility Becomes a Manufacturer
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.